Comparison of Volumetric and Bead-Based Counting of CD34 Cells by Single-Platform Flow Cytometry.

flow cytometry immunotherapy rare event detection single platform standardization stem cells transplantation

Journal

Cytometry. Part B, Clinical cytometry
ISSN: 1552-4957
Titre abrégé: Cytometry B Clin Cytom
Pays: United States
ID NLM: 101235690

Informations de publication

Date de publication:
11 2019
Historique:
received: 07 09 2018
revised: 25 01 2019
accepted: 30 01 2019
pubmed: 23 2 2019
medline: 1 9 2020
entrez: 22 2 2019
Statut: ppublish

Résumé

Over 2,000 people a year in the United Kingdom need a bone marrow or blood stem cell transplant. It is important to accurately quantify the hematopoietic stem cells to predict whether the transplant will be successful in replenishing the immune system. However, they are present at low frequency, which complicates accurate quantification. The current gold standard method is single-platform flow cytometry using internal reference counting beads to determine the concentration of CD34 cells. However, volumetric flow cytometers have the ability to measure the acquisition volume, which removes the need for reference beads for calculation of cell concentrations. In this study, we compared both methods for calculating CD34 cell concentrations in volumetric cytometers, using either the volume reading or the number of reference beads for calculation. In addition, the uncertainty of measurement for each method was estimated. The results show that both methods have similar uncertainties of measurement. Regression analysis showed low to no statistical difference in CD34 cell concentrations obtained with each method. Overall, this study suggests that the volumetric method is a valid approach but that the adoption of this technology may be hindered without some form of external calibration of volume readings to increase confidence in the measurement. © 2019 The Authors. Cytometry Part B: Clinical Cytometry published by Wiley Periodicals, Inc. on behalf of International Clinical Cytometry Society.

Sections du résumé

BACKGROUND
Over 2,000 people a year in the United Kingdom need a bone marrow or blood stem cell transplant. It is important to accurately quantify the hematopoietic stem cells to predict whether the transplant will be successful in replenishing the immune system. However, they are present at low frequency, which complicates accurate quantification. The current gold standard method is single-platform flow cytometry using internal reference counting beads to determine the concentration of CD34 cells. However, volumetric flow cytometers have the ability to measure the acquisition volume, which removes the need for reference beads for calculation of cell concentrations.
METHOD
In this study, we compared both methods for calculating CD34 cell concentrations in volumetric cytometers, using either the volume reading or the number of reference beads for calculation. In addition, the uncertainty of measurement for each method was estimated.
RESULTS
The results show that both methods have similar uncertainties of measurement. Regression analysis showed low to no statistical difference in CD34 cell concentrations obtained with each method.
CONCLUSIONS
Overall, this study suggests that the volumetric method is a valid approach but that the adoption of this technology may be hindered without some form of external calibration of volume readings to increase confidence in the measurement. © 2019 The Authors. Cytometry Part B: Clinical Cytometry published by Wiley Periodicals, Inc. on behalf of International Clinical Cytometry Society.

Identifiants

pubmed: 30790450
doi: 10.1002/cyto.b.21773
pmc: PMC6899615
doi:

Substances chimiques

Antigens, CD34 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

508-513

Informations de copyright

© 2019 The Authors. Cytometry Part B: Clinical Cytometry published by Wiley Periodicals, Inc. on behalf of International Clinical Cytometry Society.

Références

J Biol Regul Homeost Agents. 2004 Jul-Dec;18(3-4):305-12
pubmed: 15786697
Cytometry B Clin Cytom. 2003 Mar;52(1):37-9
pubmed: 12599180
J Hematother. 1996 Jun;5(3):213-26
pubmed: 8817388
Cytometry. 1998 Jun 15;34(3):128-42
pubmed: 9696157
Clin Chem. 1979 Mar;25(3):432-8
pubmed: 262186
Transfus Med. 2012 Jun;22(3):205-10
pubmed: 22519551
Cytometry. 2001 Feb 1;43(2):154-60
pubmed: 11169581
J Res Natl Inst Stand Technol. 2014 Dec 29;119:629-43
pubmed: 26601048
Bone Marrow Transplant. 2002 Apr;29(8):699-703
pubmed: 12180116
Cytotherapy. 2012 May;14(5):621-9
pubmed: 22428601
Blood Transfus. 2014 Jul;12(3):416-20
pubmed: 24887218
Cytometry B Clin Cytom. 2019 Nov;96(6):508-513
pubmed: 30790450
Stem Cells. 1998;16(4):294-300
pubmed: 9708452

Auteurs

Luisa Saraiva (L)

Biotherapeutics group, National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK.

Lili Wang (L)

Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, Maryland, 20899, United States of America.

Martin Kammel (M)

Division of Medical Physics and Metrological Information Technology, Physikalisch-Technische Bundesanstalt (PTB), Berlin, 10587, Germany.

Andreas Kummrow (A)

Division of Medical Physics and Metrological Information Technology, Physikalisch-Technische Bundesanstalt (PTB), Berlin, 10587, Germany.

Eleanor Atkinson (E)

Biostatistics, National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK.

Ji Youn Lee (JY)

Center of Length, Korea Research Institute of Standards and Science (KRISS), Daejeon, Korea.

Burhanettin Yalcinkaya (B)

TUBITAK UME (National Metrology Institute of Turkey), Gebze, Turkey.

Muslum Akgöz (M)

TUBITAK UME (National Metrology Institute of Turkey), Gebze, Turkey.

Jana Höckner (J)

Department of Transfusion Medicine, Staedtisches Klinikum Karlsruhe, Academic Hospital of the University of Freiburg, Freiburg, Germany.

Andreas Ruf (A)

Department of Transfusion Medicine, Staedtisches Klinikum Karlsruhe, Academic Hospital of the University of Freiburg, Freiburg, Germany.

Andrea Engel (A)

Becton Dickinson, BD Life Sciences, Tullastrasse 8-12, 69126, Heidelberg, Germany.

Yu-Zhong Zhang (YZ)

Protein and Cell Analysis, Thermo Fisher Scientific, Waltham, Massachusetts, USA.

Orla O'Shea (O)

UK Stem Cell Bank, UK.

Maria Paola Sassi (MP)

Istituto Nazionale di Ricerca Metrologica (INRIM), Torino TO, Italy.

Carla Divieto (C)

Istituto Nazionale di Ricerca Metrologica (INRIM), Torino TO, Italy.

Tamara Lekishvili (T)

Health Science & Innovation. LGC Ltd. Queens Road, Teddington, Middlesex, TN11 0LY, UK.

Jonathan Campbell (J)

Health Science & Innovation. LGC Ltd. Queens Road, Teddington, Middlesex, TN11 0LY, UK.

Yingying Liu (Y)

National Institute of Metrology (NIM), Beijing Shi, China.

Jing Wang (J)

National Institute of Metrology (NIM), Beijing Shi, China.

Richard Stebbings (R)

Biotherapeutics group, National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK.

Adolfas K Gaigalas (AK)

Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, Maryland, 20899, United States of America.

Peter Rigsby (P)

Biostatistics, National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK.

Jörg Neukammer (J)

Division of Medical Physics and Metrological Information Technology, Physikalisch-Technische Bundesanstalt (PTB), Berlin, 10587, Germany.

Sandrine Vessillier (S)

Biotherapeutics group, National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH